Hua Zhou

Title: Innovations of Hua Zhou in CAR-T Cell Technology

Introduction

Hua Zhou is an accomplished inventor based in Hercules, California. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptor (CAR) T-cell therapies. His innovative work has the potential to transform cancer treatment.

Latest Patents

Hua Zhou holds a patent for "Flag tagged CD19-CAR-T cells." This invention provides CAR-T cells modified to express a CAR fusion protein that includes a single-chain variable fragment (scFv) targeting the tumor antigen CD19. The design incorporates a FLAG tag, which enhances the functionality of the CAR-T cells. Notably, using CD19-FLAG CAR-T cells results in reduced cytokine levels, such as Interferon-γ, IL-2, and IL-6, compared to traditional CD19 CAR-T cells.

Career Highlights

Throughout his career, Hua Zhou has worked with prominent companies in the biotechnology sector. He has been associated with Promab Biotechnologies, Inc. and Forevertek Biotechnology Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Hua Zhou has collaborated with notable professionals in his field, including Lijun Wu and Vita Golubovskaya. Their combined efforts have further advanced the research and development of CAR-T cell therapies.

Conclusion

Hua Zhou's contributions to CAR-T cell technology exemplify the impact of innovation in biotechnology. His patented work and collaborations highlight the importance of teamwork in advancing medical science. The potential of his inventions continues to inspire future research in cancer treatment.